INFU
InfuSystem Holdings, Inc. AMEX Listed Dec 27, 2007$9.42
+7.66%
vs $8.75
Mkt Cap $198.7M
52w Low $5.41
74.5% of range
52w High $10.79
50d MA $9.50
200d MA $9.36
P/E (TTM)
30.4x
EV/EBITDA
7.9x
P/B
3.4x
Debt/Equity
0.1x
ROE
11.6%
P/FCF
8.3x
RSI (14)
57.80
ATR (14)
$0.36
Beta
1.55
50d MA
$9.50
200d MA
$9.36
Avg Volume
230.5K
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
3851 West Hamlin Road · Rochester Hills, MI 48309 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 10.14 | -17.8% | -11.5% | -6.2% | -0.5% | +0.5% | -2.4% | — |
| Feb 24, 2026 | AMC | 0.07 | 0.10 | +42.9% | 8.60 | +1.2% | -0.5% | +7.4% | -4.6% | +5.9% | -1.2% | — |
| Nov 4, 2025 | AMC | 0.08 | 0.11 | +37.5% | 9.46 | +1.0% | +5.7% | +2.9% | -3.6% | +1.7% | +3.6% | — |
| Aug 5, 2025 | AMC | 0.03 | 0.12 | +300.0% | 6.07 | +2.1% | +18.1% | +4.9% | +17.4% | -2.6% | +9.7% | — |
| May 8, 2025 | AMC | -0.03 | -0.01 | +66.7% | 5.47 | -0.2% | -1.8% | +2.0% | +4.9% | -0.3% | +4.7% | — |
| Mar 4, 2025 | AMC | 0.08 | 0.04 | -50.0% | 6.47 | +1.9% | -3.7% | +0.3% | -2.2% | -7.7% | -1.2% | — |
| Nov 7, 2024 | AMC | 0.06 | 0.08 | +33.3% | 7.34 | -0.1% | +6.4% | +16.0% | +5.0% | -6.1% | +0.4% | — |
| Aug 8, 2024 | AMC | 0.04 | 0.03 | -18.3% | 6.00 | +0.3% | +0.0% | +0.0% | +11.0% | +1.7% | -2.2% | — |
| May 9, 2024 | AMC | -0.01 | -0.05 | -350.1% | 7.56 | -0.4% | -3.7% | -4.4% | -1.0% | -2.9% | -5.2% | — |
| Mar 14, 2024 | AMC | 0.00 | 0.00 | +0.0% | 9.02 | -0.4% | +2.9% | -3.9% | -0.9% | +0.5% | +1.2% | — |
| Nov 7, 2023 | AMC | 0.03 | 0.03 | +20.0% | 9.15 | -1.2% | -5.5% | -0.6% | -0.1% | +2.4% | +5.7% | — |
| Aug 3, 2023 | AMC | 0.00 | 0.02 | +501.5% | 9.90 | +1.0% | +5.1% | +5.0% | +1.8% | +1.1% | +0.1% | — |
| May 4, 2023 | AMC | -0.01 | -0.02 | -199.4% | 8.48 | +0.7% | +6.7% | -3.6% | +0.9% | +0.2% | +1.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 | Roth Capital | Maintains | Buy → Buy | — | $8.60 | $8.70 | +1.2% | -0.5% | +7.4% | -4.6% | +5.9% | -1.2% |
| Nov 5 | Roth Capital | Maintains | Buy → Buy | — | $9.46 | $9.55 | +1.0% | +5.7% | +2.9% | -3.6% | +1.7% | +3.6% |
| Apr 26 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $22.27 | $22.80 | +2.4% | -0.3% | +1.2% | +0.6% | +0.6% | -0.6% |
| Aug 31 | Craig-Hallum | Maintains | Buy → Buy | — | $14.13 | $14.99 | +6.1% | +3.0% | -3.4% | -0.2% | -1.4% | -2.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Lachance CarrieDir/Off | President and CEO | Buy | 1,000 | $8.46 | $8K | 238,123 | -2.38% | +8.65% |
| May 8, 2026 | Steele Barry GOff | Executive VP and CFO | Buy | 7,000 | $8.71 | $61K | 96,590 | -2.38% | +8.65% |
| May 8, 2026 | GENDRON PAUL ANDREWDir | — | Buy | 5,000 | $8.88 | $44K | 70,000 | -2.38% | +8.65% |
| May 8, 2026 | Lachance CarrieDir/Off | President and CEO | Buy | 2,000 | $8.83 | $18K | 237,123 | -2.38% | +8.65% |
8-K · 5.02
!!! Very High
InfuSystem Holdings, Inc. -- 8-K 5.02: Executive Change
May 14
8-K · 2.02
!! High
InfuSystem Holdings, Inc. -- 8-K 2.02: Earnings Results
InfuSystem Holdings reported Q1 2026 earnings results on May 7, showing operational performance and financial condition updates that investors can review in the attached press release.
May 7
8-K · 4.01
!!! Very High
Unknown — 8-K 4.01: Auditor Change / Resignation
Deloitte's resignation as INFU's auditor suggests potential accounting disputes or internal control concerns, creating uncertainty about financial reliability and potentially triggering stock volatility until a replacement auditor is appointed.
Mar 19
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
InfuSystem's conference participation announcement signals management confidence in the business outlook and provides an investor relations opportunity to discuss strategy, potentially supporting or stabilizing stock sentiment near the event date.
Mar 16
8-K · 7.01
! Medium
InfuSystem Holdings, Inc. -- 8-K 7.01: Regulation FD Disclosure
InfuSystem disclosed material information through Regulation FD, suggesting the company wants to ensure all investors receive information simultaneously, which could signal either positive developments or proactive transparency management that may affect stock valuation.
Feb 27
8-K
InfuSystem Holdings, Inc. -- 8-K Filing
InfuSystem Holdings achieved seventh consecutive year of record revenues at $143.4 million with net income surging 183% to $6.6 million and adjusted EBITDA reaching $31.5 million, demonstrating strong operational profitability and cash generation.
Feb 24
8-K · 7.01
! Medium
InfuSystem Holdings, Inc. -- 8-K 7.01: Regulation FD Disclosure
InfuSystem Holdings will hold a February 24, 2026 investor conference call to discuss company updates, providing shareholders direct access to management guidance and financial performance insights.
Feb 17
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | First Eagle Investment Management, Llc | 1,442,742 | $13M | Reduced | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 860,263 | $8M | New | Mar 2026 |
| 3 | Acadian Asset Management Llc | 634,044 | $6M | Added | Mar 2026 |
| 4 | Renaissance Technologies Llc | 566,809 | $5M | Reduced | Mar 2026 |
| 5 | Meros Investment Management, Lp | 469,408 | $4M | Reduced | Mar 2026 |
| 6 | Arrowstreet Capital, Limited Partnership | 368,712 | $3M | Reduced | Mar 2026 |
| 7 | Millennium Management | 354,559 | $3M | Added | Mar 2026 |
| 8 | Essex Investment Management Co Llc | 299,332 | $3M | Added | Mar 2026 |
| 9 | Marshall Wace, Llp | 265,209 | $2M | Added | Mar 2026 |
| 10 | Susquehanna International Group, Llp | 234,331 | $2M | Reduced | Mar 2026 |
| 11 | Two Sigma Investments, Lp | 185,411 | $2M | Added | Mar 2026 |
| 12 | Teton Advisors, Llc | 185,000 | $2M | — | Mar 2026 |
| 13 | North Star Investment Management Corp. | 182,000 | $2M | Added | Mar 2026 |
| 14 | Citadel Advisors Llc | 169,954 | $2M | Added | Mar 2026 |
| 15 | Jane Street Group, Llc | 158,163 | $1M | Added | Dec 2025 |
| 16 | Russell Investments Group, Ltd. | 130,058 | $1M | Reduced | Mar 2026 |
| 17 | Morgan Stanley | 132,974 | $1M | Added | Dec 2025 |
| 18 | Man Group Plc | 112,106 | $1M | Added | Mar 2026 |
| 19 | Bnp Paribas Financial Markets | 110,598 | $1M | Added | Mar 2026 |
| 20 | Sei Investments Co | 104,757 | $967K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$198.7M
Enterprise Value
$199.0M
P/E (TTM)
30.39x
Forward P/E
22.64x
PEG Ratio
0.15x
P/B
3.39x
P/S
1.39x
P/FCF
8.33x
EV/EBITDA
7.89x
Shares Out
21.1M
Financials (TTM)
Revenue
$143.4M
Net Income
$6.6M
EBITDA
$25.2M
Free Cash Flow
$23.8M
Op Cash Flow
$24.4M
EPS Basic
$0.32
EPS Diluted
$0.31
EPS Forward
$0.42
Gross Margin
56.0%
Op Margin
8.3%
Net Margin
4.6%
Balance Sheet
Total Assets
$100.6M
Total Liab.
$43.2M
Total Equity
$57.3M
Cash
$3.2M
LT Debt
$3.4M
Book Value/Sh
$2.77
Debt/Equity
0.06x
Current Ratio
1.80
Quick Ratio
1.53
Returns & Growth
ROE
11.6%
ROA
6.6%
ROIC
14.8%
Rev Growth YoY
+6.4%
EPS Growth YoY
+190.9%
Price Returns
2W
+5.3%
1M
-10.5%
3M
+3.4%
6M
-2.3%
12M
+56.9%
Technicals
52W High
$10.79
52W Low
$5.41
50d MA
$9.50
200d MA
$9.36
RSI (14)
57.80
ATR (14)
$0.36
Beta
1.55
Avg Volume
231K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$15.00
High
$15.00
Low
$15.00
Median
$15.00
Data updated apr 25, 2026 3:35pm
· Source: financialmodelingprep.com